Herantis Pharma granted €3.6m to assess treatment for Parkinson’s disease
In the UK, the progressive neurodegenerative condition affects around 153,000 people
Read More
Tag: Parkinson’s UK Virtual Biotech Programme
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
